We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Common Contracts
99 similar Collaboration and License Agreement contracts by Lexicon Genetics Inc/Tx, Cytokinetics Inc, Memory Pharmaceuticals Corp, others
ANDCollaboration and License Agreement • November 9th, 2006 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
Standard Contracts
REDACTED COPY COLLABORATION AND LICENSE AGREEMENT by and betweenCollaboration and License Agreement • September 22nd, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
REDACTED COPY COLLABORATION AND LICENSE AGREEMENT by and betweenCollaboration and License Agreement • August 18th, 2006 • Trubion Pharmaceuticals, Inc • Pharmaceutical preparations • New York
WYETHCollaboration and License Agreement • June 2nd, 2006 • Trubion Pharmaceuticals, Inc • New York
Exhibit 10.5 Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT dated as of March 17, 2006 by and between PTC THERAPEUTICS, INC.Collaboration and License Agreement • March 31st, 2006 • PTC Therapeutics, Inc. • New York
INTRODUCTIONCollaboration and License Agreement • March 31st, 2006 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New York
SECOND AMENDED AND RESTATED COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 3rd, 2006 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Delaware
BACKGROUNDCollaboration and License Agreement • November 14th, 2005 • SGX Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
RECITALSCollaboration and License Agreement • November 1st, 2005 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Texas
BACKGROUNDCollaboration and License Agreement • September 2nd, 2005 • SGX Pharmaceuticals, Inc. • Delaware
EXHIBIT 10.1 Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT THIS COLLABORATION AND LICENSE AGREEMENT (this "Agreement") is dated as of...Collaboration and License Agreement • July 29th, 2005 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Delaware
Exhibit 10.42 COLLABORATION AND LICENSE AGREEMENT THIS COLLABORATION AND LICENSE AGREEMENT (this "AGREEMENT") dated as of June 17, 2005, (the "EFFECTIVE DATE") is by and between Avalon Pharmaceuticals, Inc. ("AVALON"), a Delaware Corporation, having a...Collaboration and License Agreement • June 23rd, 2005 • Avalon Pharmaceuticals Inc • Pharmaceutical preparations • New York
ANDCollaboration and License Agreement • December 21st, 2004 • Cancervax Corp • Biological products, (no disgnostic substances) • New York
COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN MERCK & CO., INC. AND ALNYLAM PHARMACEUTICALS, INC.Collaboration and License Agreement • August 12th, 2004 • Alnylam Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
EXHIBIT 10.15 Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • July 16th, 2004 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Delaware
EXECUTION COPY CONFIDENTIAL MATERIALS OMITTED AND FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • May 11th, 2004 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
RECITALSCollaboration and License Agreement • April 29th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • New York
RECITALSCollaboration and License Agreement • April 27th, 2004 • Cytokinetics Inc • Pharmaceutical preparations • New York
INTRODUCTIONCollaboration and License Agreement • March 17th, 2004 • Memory Pharmaceuticals Corp • Pharmaceutical preparations • New Jersey
RECITALSCollaboration and License Agreement • March 12th, 2004 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Delaware
EXHIBIT 10.15 Confidential materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 12th, 2004 • Lexicon Genetics Inc/Tx • In vitro & in vivo diagnostic substances • Delaware
EXECUTION COPY CONFIDENTIAL MATERIALS OMITTED AND FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE SUCH OMISSIONS. COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 11th, 2004 • Momenta Pharmaceuticals Inc • New York
RECITALSCollaboration and License Agreement • January 27th, 2004 • Cytokinetics Inc • New York
INTRODUCTIONCollaboration and License Agreement • December 23rd, 2003 • Memory Pharmaceuticals Corp • New Jersey
INTRODUCTIONCollaboration and License Agreement • August 20th, 2003 • Nitromed Inc • Massachusetts
Exhibit 10.33 Portions of this exhibit were omitted and filed separately with the Secretary of the Commission pursuant to an application for confidential treatment filed with the Commission pursuant to Rule 24b-2 under the Securities Exchange Act of...Collaboration and License Agreement • August 14th, 2003 • Viropharma Inc • Pharmaceutical preparations • New Jersey
RECITALS:Collaboration and License Agreement • August 7th, 2003 • Introgen Therapeutics Inc • Pharmaceutical preparations • Texas
August 14, 2002 Isis Pharmaceuticals, Inc. 2292 Faraday Avenue Carlsbad, California 92008 Re: Collaboration and License Agreement; Master Agreement ----------------------------------------------------- Gentlemen: Reference is hereby made to the...Collaboration and License Agreement • March 31st, 2003 • Hybridon Inc • Biological products, (no disgnostic substances)
AMENDMENT OF MEDNOSTICS(TM) COLLABORATION AND LICENSE AGREEMENT BETWEEN GENAISSANCE PHARMACEUTICALS, INC. AND BIOGEN, INC.Collaboration and License Agreement • March 31st, 2003 • Genaissance Pharmaceuticals Inc • Services-commercial physical & biological research
RECITALSCollaboration and License Agreement • February 25th, 2003 • Corixa Corp • Biological products, (no disgnostic substances) • Washington
Wyeth Research L Patrick Gage, Ph.D. PO. Box 8299 President Philadelphia. PA 19101-8299 484 865 5870 tel 484 865 9094 fax Wyeth May 29, 2002 Michel de Rosen President and Chief Executive Officer ViroPharma Incorporated 405 Eagleview Boulevard Exton,...Collaboration and License Agreement • August 12th, 2002 • Viropharma Inc • Pharmaceutical preparations
RECITALSCollaboration and License Agreement • July 22nd, 2002 • Hyseq Inc • In vitro & in vivo diagnostic substances • California
RECITALS:Collaboration and License Agreement • May 15th, 2002 • Introgen Therapeutics Inc • Pharmaceutical preparations • Texas
Exhibit 10.1 D THIRD AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT Third amendment, dated March 25, 2002, (this "Amendment"), to the Collaboration and License Agreement and the Subscription Agreement dated June 12, 1998, each as amended through...Collaboration and License Agreement • May 9th, 2002 • Aphton Corp • Biological products, (no disgnostic substances) • New York
RECITALSCollaboration and License Agreement • April 1st, 2002 • Hyseq Inc • In vitro & in vivo diagnostic substances • California